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Sigma-1 receptor agonist PRE084 is protective against
mutant huntingtin-induced cell degeneration:
involvement of calpastatin and the NF-jB pathway
A Hyrskyluoto1,2, I Pulli3, K To¨rnqvist2,3, T Huu Ho2, L Korhonen1,2,4,5 and D Lindholm*,1,2,5
Alterations in mitochondria and increased oxidative stress are associated with the disease progression in Huntington’s disease (HD).
Endoplasmic reticulum (ER) stress and oxidative damage are linked through the close communication between the ER and
mitochondria. Sigma-1 receptor (Sig-1R) is a chaperone protein in the ER that is involved in ER stress regulation, but little is
known about its role in HD or the mechanisms for cell protection. Here we show that the Sig-1R agonist, PRE084 increases cell
survival and counteracts the deleterious effects caused by N-terminal mutant huntingtin proteins in neuronal PC6.3 cells.
Particularly, PRE084 increased the levels of cellular antioxidants by activating the NF-jB pathway that is compromised by the
expression of mutant huntingtin proteins. These results show that the Sig-1R agonist has beneficial effects in models of HD and
that compounds affecting the Sig-1R may be promising targets for future drug development in HD.
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Huntington’s disease (HD) is an autosomal, dominantly
inherited neurodegenerative disorder that is caused by an
expansion of cytosine–adenine–guanine (CAG) repeats in the
first exon of the huntingtin gene IT15, which encodes the
huntingtin protein.1 The expansion of CAG repeats in
huntingtin leads to the formation of neuronal intracellular
and intranuclear aggregates.2 HD is characterized by severe
motor and cognitive symptoms due to brain atrophy with loss
of neurons especially in the striatum and cerebral cortex. The
wild-type huntingtin protein (350 kDa) is expressed in most
tissues and participates in protein trafficking, postsynaptic
signaling, vesicle transport, transcriptional regulation, and in
regulation of cell death. The precise molecular mechanisms
by which mutant huntingtin induces nerve cell degeneration
are not completely understood,3 but both loss-of-function and
gain-of-function mechanisms have been described in HD.4
The mutant protein is cleaved to form N-terminal fragments
containing the first 100–150 residues including the polygluta-
mine repeats that are thought to be the toxic species found in
aggregates.5 Polyglutamine-expanded proteins cause disrup-
tion of many intracellular pathways including those in the
endoplasmic reticulum (ER) leading to ER stress.6 ER stress
triggers the unfolded protein response (UPR) that is mediated
by three proximal ER sensors: PERK, ATF6, and IRE1.
The UPR is a cellular adaptation mechanism but prolonged or
severe ER stress can also activate signaling pathways leading
to apoptosis.7 ER stress and oxidative damage are linked
through the close communication between the ER and
mitochondria. Oxidative stress can lead to a toxic increase
in reactive oxygen species (ROS) production, which causes
damage to cell membranes and aborts normal cellular
functions.3,8 Previous studies have shown that oxidative
stress has a role in the neurodegenerative processes in HD.3,9
The Sigma receptors are non-opioid receptor proteins10
that are classified into two major subtypes; Sigma-1 and
Sigma-2 receptors.11 The Sigma-1 receptor (Sig-1R) has
been cloned12 but the sequence of the Sigma-2 receptor is so
far not known. Hayashi and Su13 have shown that Sig-1R
is a chaperone protein located at the ER that specifically
targets the mitochondria-associated ER membrane (MAM).
Sig-1R is thought to form a Ca2þ -sensitive chaperone
complex with Bip prolonging Ca2þ signaling from ER into
mitochondria by stabilizing the inositol 1,4,5-trisphosphate
receptor (IP3R). Sig-1R is upregulated by ER stress and
overexpression of Sig-1R regulates UPR signaling.13 It is also
known that Sig-1Rs can translocate from MAM to other parts
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of the ER and this event may be provoked by ER stress.
Knockdown of Sig-1R is shown to promote apoptosis induced
by ER stress and by ROS.13,14
The function of Sig-1R has also been linked to neurode-
generative disorders as shown by analyses of materials from
patients afflicted by these diseases. Thus, a postmortem
study reported that Sig-1Rs were reduced in the hippocampus
in Alzheimer’s disease (AD)15 and Sig-1R levels were also
decreased in specimens from patients with early Parkinson’s
disease.16 A recent study reported a mutation in Sig-1R in
patients with juvenile amyotrophic lateral sclerosis (ALS),17
however little is so far known about the role of Sig-1R in HD.
In this work, we have studied the role of Sig-1R
and its agonist 2-(4-morpholinoethyl)-1-phenylcyclohexane-
1-carboxylate hydrochloride (PRE084) in a cellular model of
HD with overexpression of wild-type and mutant huntingtin
proteins in neuronal PC6.3 cells. We show that Sig-1R protein
levels were decreased in mutant huntingtin-expressing cells
and that PRE084 can restore the levels. PRE084 also
protected PC6.3 cells from the deleterious effects of mutant
huntingtin proteins via the upregulation of NF-kB-p65 result-
ing in increased levels of cellular antioxidants and decreased
oxidative stress. Increased calpastatin levels were crucial for
the beneficial effects by PRE084 and Sig-1R overexpression
whereas changes in mitochondrial calcium were not obvious
in mutant huntingtin-expressing cells.
Results
Expression of Sig-1R protein is decreased in mutant
huntingtin protein-expressing cells. Using neuronal
PC6.3 cells, we found that the protein levels of Sig-1R were
decreased in cells expressing N-terminal huntingtin fragment
proteins having 120 polyglutamine repeats (120Q-huntigtin)
(Figures 1a and b). However, cells expressing the
18Q-huntingtin-fragment protein exhibited Sig-1R levels
similar to those in controls (Figure 1a). Cells expressing the
full-length diseases- huntingtin protein (75QFL) had reduced
levels of Sig-1R levels (Figures 1c and d), whereas cells
overexpressing wild-type 17Q-huntingtin (17QFL) were not
different from controls (Figures 1c and d). Stimulation of the
PC6.3 cells with the Sig-1R agonist PRE084 elevated
the Sig-1R levels reduced by mutant huntingtin proteins
(Figures 1b and d). To study whether the changes in Sig-1R
occurred at the RNA levels, we performed quantitative
PCR (qPCR) that showed no significant alterations in
Sig-1R mRNA (Supplementary Figure 1). This suggests
that the regulation of Sig-1R by its agonist occurs at the
Figure 1 Levels of Sig-1Rs in PC6.3 cells expressing mutant huntingtin proteins. (a) Immunoblot. Cells were transfected for 24 h with expression constructs encoding
different N-terminal huntingtin fragment proteins with 18Q and 120Q repeats. The compound 0.3mM PRE084 was added as indicated. The levels of Sig-1R were analyzed as
described in the Materials and Methods. Sig-1R was decreased in cells expressing 120Q-huntingtin and PRE084 restored this level. b-actin was used as control. Expression of
the GFP-huntingtin constructs is also shown. (b) Quantification was done using ImageJ. Values represent means±S.D., n¼ 3. **Po0.01 for 120Q versus C and for
PRE084þ 120Q versus 120Q. (c and d) Immunoblot and quantification. Cells were transfected for 48 h with FL huntingtin constructs having either 17 (17Q) or 75
polyglutamine (75Q) repeats. Sig-1R protein levels were decreased in cells expressing the disease-causing 75Q-huntingtin protein and restored by treatment with 0.3mM
PRE084. b-actin was used as control. Quantification was done as above. Values represent means ±S.D., n¼ 3. **Po0.01 for 75Q versus C and for PRE084þ 75Q
versus 75Q. (e) Confocal microscopy. Immunofluorescence (green) of PC6.3 cells transfected for 24 h with huntingtin fragment proteins containing 18Q (upper panels) and
120Q repeats (middle panels). Immunostaining was done using specific antibody against Sig-1R (red fluorescence). Sig-1R is present in part in cytoplasmic aggregates in cells
expressing120Q-huntingtin in the merged picture (yellow color, arrow). Scale bar, 15 mm. Lower panels, immunostaining using the EM48 antibody recognizing mutant
huntingtin aggregates. Note a partial co-localization with Sig-1R
Sigma-1 receptor and Huntington’s disease
A Hyrskyluoto et al
2
Cell Death and Disease
post-transcriptional level. As shown using confocal
microscopy, there was a co-localization of Sig-1Rs and the
120Q-huntingtin-fragment protein within the cytoplasmic
aggregates in the PC6.3 cells (arrow in Figure 1e).
This was not observed in PC6.3 cells expressing the
18Q-huntingtin-fragment protein (Figure 1e). The reason for
this is not clear but it is known that Sig-1R has a function as a
chaperone and might bind to protein aggregates.
The Sig-1R agonist PRE084 counteracts cell degeneration
and caspase activation induced by N-terminal mutant
huntingtin proteins. We previously reported that expression
of N-terminal mutant huntingtin proteins in PC6.3 cells leads to
cell death characterized by activation of various caspases.6,9
To study whether the Sig-1R has a role in cell degeneration,
we stimulated PC6.3 cells with PRE084 after transfection of
cells with N-terminal mutant huntingtin proteins. Data showed
that PRE084 protected PC6.3 cells against mutant
huntingtin-induced cell degeneration as shown by estimation
of cell viability (Figure 2a) and counting the number of
apoptotic nuclei (Figure 2b). PRE084 also counteracted
caspase-3 cleavage (17 kDa fragment) that was induced by
mutant huntingtin proteins (Figures 2c and d), and reduced the
cleavage of PARP that is a target for the active caspase-3
(Figure 2c). Using a commercial kit, we observed that the
expression of 120Q-huntingtin induced caspase-3 activity
that could be blocked by PRE084 (Figure 2e). Previous
studies have shown that procaspase-12, which resides in the
ER is cleaved in cells expressing the 120Q-huntingtin-
fragment proteins.6,9 PRE084 also prevented the cleavage
of caspase-12 in 120Q-huntingtin-expressing cells (Figures 2f
and g), suggesting a cytoprotective effect of PRE084 related
Figure 2 Stimulation with PRE084 counteracts the deleterious effects caused by N-terminal mutant huntingtin proteins. PC6.2 cells expressing 18Q- and 120Q-containing
N-terminal huntingtin fragment proteins were left untreated or treated with the Sig-1R agonist, PRE084 as described in the Materials and Methods. (a) Cell viability was
assessed after 24 h by the MTT assays as described in the Materials and Methods. PRE084 reduced cell death induced by the 120Q mutant huntingtin. Values represent
means±S.D., n¼ 3. *Po0.05 for 120Q versus C and for PRE084þ 120Q versus 120Q. (b) Cell death was assessed by counting number of apoptotic nuclei in 18Q and
120Q-huntingtin-fragment protein-expressing cells incubated for 24 h and 48 h without or with 0.3mM PRE084. Cell death increased in cells transfected with the 120Q
huntingtin and this was reduced by PRE084. Values represent means±S.D., n¼ 3. **Po0.01 for 120Q versus 18Q at 24 h and *Po0.05 at 48 h. (c and d) Immunoblot and
quantification. Expression of 120Q-huntingtin-induced cleaved caspase-3 (17 kDa band) and this was reduced by addition of 0.3 mM PRE084. The cleavage of PARP (89 kDa
band) a downstream substrate of caspase-3 was also decreased by PRE084. b-actin was used as control. Values represent means±S.D., n¼ 3. **Po 0.01 for 120Q versus
C and for PRE084þ 120Q versus 120Q. (e) Activity of caspase-3 was measured as described in the Materials and methods. Note an increase in cells expressing 120Qmutant
huntingtin that as reduced by 0.3mM PRE084. Values represent means±S.D., n¼ 3. **Po0.01 for 120Q versus C and for PRE084þ 120Q versus 120Q. (f and g)
Immunoblot and quantification. Expression of 120Q-huntingtin-induced cleaved caspase-12 (36 kDa band) and this was reduced by addition of 0.3mM PRE084. b-actin was
used as control. Values represent means±S.D., n¼ 3. *Po 0.05 for 120Q versus C
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to reduced ER stress. To study whether the increase in
cell viability inversely correlate with mutant huntingtin
aggregates, we treated 120Q-huntingtin-expressing cells with
PRE084 for 24 h. Data showed that the amount of mutant
huntingtin aggregates was not altered by PRE084 treatments
nor did the number of cells with aggregates change under
these conditions (Supplementary Figure 2).
Mitochondrial Ca2þ levels are not affected by mutant
huntingtin proteins or by PRE084 stimulations. Previous
data shows that mutant huntingtin can modulate calcium
signaling in neuronal cells through an interaction with
IP3R1,18 and hat IP3R1 is negatively regulated in a mouse
model for HD.19 Sig-1R is enriched within the MAM region in
the ER13 and influences Ca2þ signaling from ER into
mitochondria by stabilizing IP3R. Given the regulation of
Sig-1R by mutant huntingtin (Figure 1), we were interested to
study whether the mutant huntingtin proteins may also
influence mitochondrial [Ca2þ ] ([Ca2þ ]mito) during
IP3-induced calcium release and whether PRE084 may
affect this. To accomplish this, cells were transfected with
aequorin targeted to the mitochondrial matrix in conjunction
with plasmids expressing either the full-length 17QFL
huntingtin or the disease-causing 75Q huntingtin protein
plasmids. Control cells were co-transfected with the vector
plasmid. The cells were left untreated or pretreated with
0.3mM PRE084 for 20 h followed by stimulation with 100 nM
bradykinin, and the [Ca2þ ]mito was then measured as
described in the Materials and methods. Data showed that
neither 17QFL nor 75QFL huntingtin altered [Ca2þ ]mito in the
cells when compared with untreated controls (Figures 3a
and c). Incubation with PRE084 led to a slight increased
[Ca2þ ]mito response but this was not significant and
[Ca2þ ]mito was not changed in cells expressing 17QFL or
75QFL huntingtin compared with the control (Figures 3b
and d). Taken together, the results show that the mutant
huntingtin proteins did not influence mitochondrial [Ca2þ ]
levels in neuronal PC6.3 cells. In keeping with our previous
data using120Q mutant fragment huntingtin protein,9 the
expression of 75QFL also did not elevate cytosolic Ca2þ in
the PC6.3 neuronal cells (Supplementary Figure 3).
Stimulation with PRE084 increases cellular antioxidants
and reduces ROS in mutant huntingtin-expressing cells.
We have previously shown that the mitochondrial antioxidant,
Sod2 and Trx2, and the cytosolic antioxidants, Sod1 and
catalase, are downregulated by the N-terminal mutant hunting-
tin proteins in PC6.3 cells through downregulation of NF-kB
signaling.9 The decreased levels of antioxidants were also
accompanied by increased production of ROS in cells
expressing mutant huntingtin.9 To study whether the cytopro-
tective effect of Sig-1R involves antioxidants, we stimulated
cells expressing 120-huntingtin fragment protein with PRE084.
Compiling of the data showed that PRE084 was able to
increase the cellular levels of various antioxidants that were
downregulated by the 120Q-huntingtin (Figures 4a–e). Along
this line, stimulation of PC6.3 cells with PRE084 reduced
intracellular ROS levels that were elevated by the disease-
causing 75QFL huntingtin protein (Figure 4f). These results
show that PRE084 is able to decrease the levels of ROS and
oxidative stress in neuronal PC6.3 cells expressing mutant
huntingtin proteins via the upregulation of cellular antioxidants.
Figure 3 No effects of huntingtin proteins and PRE084 on mitochondrial calcium responses. Mitochondrial Ca2þ concentrations were measured in PRE084-treated and
in huntingtin protein-overexpressing cells as described in the Materials and Methods. (a and b) Representative traces of mitochondrial Ca2þ concentrations ([Ca2þ ]mito) in
PC6.3 cells expressing FL huntingtin constructs having 17 (17QFL) and 75 polyglutamine (75QFL) repeats and employing stimulations with 100 nM bradykinin. C, control
plasmid pcDNA-expressing cells. Panel a is without pretreatment and panel b is pretreatment for 20 h with 0.3mM PRE084. There were no significant changes in [Ca2þ ]mito.
between controls and PRE084-pretreated cells or after expressing of the mutant huntingtin proteins. (c and d) Summary histograms. Values are means±S.D., n¼ 4. There
was a tendency to higher [Ca2þ ]mito following PRE084 treatment but these were not statistically significant from controls
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PRE084 increases NF-jB-p65 levels and activates NF-jB
signaling in neuronal PC6.3 cells. To study the involve-
ment of NF-kB signaling in the antioxidant effects of Sig-1R
in PC6.3 cells, we determined the levels of NF-kB-p65
(p65, RelA) protein that is important for NF-kB signaling.20
Treatment of the cells with PRE084 was able to restore the
NF-kB-p65 levels that were downregulated by the expression
of 120Q-huntingtin-fragment protein (Figures 5a and b).
Similar data was obtained using the disease-causing 75QFL
huntingtin and PRE084 (data not shown). Using a NF-kB-
luciferase reporter construct, it was also found that the
NF-kB activity was decreased in cells expressing 75QFL
huntingtin, whereas the 17QFL huntingtin had no effect
(Figure 5d). Most importantly, treatment with PRE084
prevented the decrease in NF-kB activity in 75QFL hunting-
tin-expressing cells (Figure 5c). In contrast, progesterone
that acts in part also via the Sigma-2 receptor did not have
any effect on NF-kB activity (Figure 5c).
PRE084 and overexpression of Sig-1R elevate calpastatin
in mutant huntingtin-expressing cells. Previously it was
shown that calpastatin is decreased in cells expressing the
120Q-huntingtin-fragment protein.9 The activity of calpain was
also elevated in the 120Q-huntingtin-expressing cells in line
with the function of calpastatin as an inhibitor of
calpain.9 We observed that the mRNA levels of calpains are
proteolytic enzymes activated by increased cell calcium and
are involved in the regulation of oxidative stress and other
processes in the cell.
We observed here that stimulation of the PC6.3 cells for 6 h
with PRE084 increased the calpastatin levels that are reduced
by overexpressing 120Q-huntingtin (Figures 6a and b). The
increase in calpastatin by PRE084 was accompanied by a
reduced calpain activity as shown by decreased cleavage of
the calpain substrate, a-spectrin in the PC6.3 cells (Figure 6c).
To study whether PRE084 elevate calpastatin in control cells,
we stimulated cells with the compound for up to 24 h. Data
showed that calpastatin levels were significantly induced by
PRE084 at 24 h and that overexpression of Sig-1R in the
PC6.3 cells had the same effect (Figures 6d and e). To reveal
whether calpastatin mRNA levels were also increased by
PRE084, we performed qPCR that showed no change
Figure 4 PRE084 increases cellular antioxidants and reduces free radical production in cells expressing mutant N-terminal fragment huntingtin proteins. (a) Immunoblots
were made using specific antibodies as described in the Materials and Methods. Sod1, Sod2, Trx2 and Bcl-XL were decreased in cells expressing 120Q-huntingtin-fragment
proteins but the levels were increased by PRE084. b-actin was used as control. Expression of the GFP-huntingtin constructs is shown in the lowermost panel. (b–e)
Quantification. Values represent mean±S.D., n¼ 3. *Po0.05 or **Po0.01 for 120Q versus C and for PRE084þ 120Q versus 120Q. (f) Intracellular ROS levels were
measured as described in the Materials and Methods. ROS increased in cells expressing the 75QFL huntingtin protein, and this was reduced by 0.3mM PRE084. Data were
normalized to ROS levels in control cells set 100%. Values are means±S.D., n¼ 4. *Po0.05 for 75QL versus C and for PRE084þ 75QL versus 75QL
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in calpastatin expression following PRE084 (Figure 6f). This
suggests that the Sig-1R may primarily influence the stability
or the degradation of calpastain in cells expressing mutant
huntingtin proteins.
Discussion
The present study shows that the modulation of Sig-1R in
neuronal PC6.3 cells can protect against cell degeneration
induced by mutant huntingtin proteins. The beneficial effect of
the Sig-1R agonist PRE084 was observed both in cells
expressing the 120Q-huntingtin-fragment protein and the
disease-causing 75QFL huntingtin protein. The mechanism
by which PRE084 induces neuroprotection was ascribed to
the restoration of the calpastatin and NF-kB-p65 levels in
huntingtin-expressing cells, which then upregulated various
cellular antioxidants and decreased ROS levels with a positive
effect on cell survival. We have previously shown that
inhibitors of calpain activities as well as calpastatin
overexpression increase PC6.3 cell survival and counteract
the deleterious effects caused by mutant huntingtin proteins.9
This together with the present results demonstrate that the
calpastatin/calpain system is an important regulator of NF-kB-
p65 in neuronal PC6.3 cells and that the NF-kB signaling is
adversely influenced by the mutant huntingtin proteins.
Previous studies have further shown that the IkB kinase
b (IKKb), which is involved in NF-kB signaling can contribute
to the neurotoxicity observed with mutant huntingtin.21 Here
we present evidence that the Sig-1R agonist PRE084 can
positively affect the NF-kB pathway and induce neuroprotec-
tion of cells expressing mutant huntingtin.22 In view of the
robust inhibition of cell death and various caspases observed
in the PC6.3 cells by PRE084 (Figure 2), this compound
may have also other targets in the cells that add to its
cytoprotection including effects on anti-apoptotic genes
such as Bcl-2.14,21
Previously it was shown that the levels of Sig-1R are
reduced in various neurodegenerative diseases such as AD
and PD.15,16 The mechanisms involved and the functional
significance of these changes, however, are not fully under-
stood. Recently, a mutation in Sig-1R was found in patients
with a juvenile form of ALS,17 and PRE084 was shown to
promote motoneuron survival in an animal model of ALS.23
We show here that the Sig-1R is decreased in neuronal PC6.3
after expression of mutant huntingtin proteins and can be
restored by the agonist PRE084. In cells, Sig-1R is largely
localized in the ER in the MAM sub-compartment, which
links it close to the mitochondria. We observed a partial
co-localization of Sig-1R with aggregates in mutant huntingtin
protein-expressing cells, suggesting that the Sig-1R may be
redistributed or delocalized in these cells. The agonist
PRE084 is thought to stabilize Sig-1R and may therefore
hinder its relocalization to protein aggregates containing
mutant huntingtin proteins. However, so far this remains a
possibility only, and more studies are required to reveal the
precise mechanisms by which PRE084 affects the cellular
functions of Sig-1R in neuroprotection. Here we analyzed
whether PRE084 may influence the mitochondrial [Ca2þ ]
levels, which is based upon the observations that Sig-1R is
present in MAM and stabilizes the IP3R1.13 Furthermore,
mutant huntingtin can interact with ER6,9 and modulate
calcium signaling in HD.18,19 Using the mitochondrial calcium
reporter aequorin, we show here that neither PRE084 nor
expression of mutant huntingtin proteins influenced [Ca2þ ]mito
levels in the PC6.3 cells (Figure 3). This is an important
observation, as deregulation of mitochondrial [Ca2þ ] may in
turn lead to an increased ROS production by this organelle
with deleterious functional consequences.24 PRE084 did not
directly affect the [Ca2þ ]mito in mutant huntingtin-expressing
cells compared with controls. However, PRE084 did have an
effect on the mitochondria-localized antioxidants, Sod2 and
Trx2 by increasing their levels in 120Q-huntingtin-expressing
cells (Figure 4). The increased levels of Sod2 and Trx2
probably contribute to the decrease in ROS levels observed
with PRE084. We have previously shown that Sod2 and Trx2
in cells are regulated by NF-kB signaling.9,25 The activation of
NF-kB by PRE084 may underlie the beneficial effects of this
compound in oxidative stress. Apart from the dysregulated
NF-kB signaling, there is evidence for an inhibition of
Figure 5 Stimulation with PRE084 counteracts the downregulation of
NF-kB pathway induced by mutant huntingtin proteins. (a and b) Immunoblot
and quantification. The levels of NF-kB-p65 were downregulated by expression of
120Q-huntingtin and restored by 0.3mM PRE084. b-actin was used as control.
Values represent mean±S.D., n¼ 3. **Po0.01 for 120Q versus C and *Po0.0
for PRE084þ 120Q versus 120Q. (c) NF-kB reporter assay using the luciferase
reporter plasmid was performed as described in the Materials and methods. NF-kB
activity was decreased in cells expressing FL mutant huntingtin protein (75QFL) and
this was restored by addition of 0.3mM PRE084. Progesterone stimulating also
Sigma-2 receptors did not have the same effect. Values represent mean±S.D.,
n¼ 3. *Po0.05 for 75QL versus C and for PRE084þ 75QFL versus 75QFL as well
as for Progesteronþ 75QFL versus C
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cytoprotective autophagy in the PC6.3 cells expressing
mutant huntingtin proteins.26 This in turn may increase
the amount of protein aggregates enhancing cell stress and
further disrupt protective signals in the cells leading to a
circulus vitiosus scenario. It is therefore important to try to
target the more upstream events in the cellular cascades
leading to the disease.
Since the identification of the Sig-1R-binding sites in 1982,
several selective Sig-1R ligands have been synthesized.27–31
Pharmacological studies have shown that such ligands may
have many physiological effects ranging from neuroprotection
to neuropsychiatric and anti-depressant effects.10,11,32 Of the
many compounds interacting with these receptors, the
selective Sig-1R agonists PRE084 (ref. 28)) and 1-(3,4-
dimethoxyphenethyl)-4-(3-phenylpropyl) piperazine dihy-
drochloride (SA4503)29,33 have been mostly studied. PRE084
have been shown to have beneficial effects in various models
of brain diseases including neurodegenerative and acute brain
disorders. Thus, PRE084 was shown to promote cell survival
and reduce oxidative stress caused by ischemia34 and toxicity
induced by b-amyloid peptide.35 PRE084 was also neuropro-
tective against nerve avulsion injury36 and it acts on motoneur-
ons both in vivo and in vitro.23,37 Here we show that PRE084
counteracts the deleterious effects of mutant huntingtin
proteins in neuronal PC6-3 cells by increasing calpastatin
and by activating NF-kB signaling. Moreover the Sig-1R was
reduced in mutant huntingtin proteins expressing cells and
could be restored by PRE084 treatments. It has previously
been shown that calpain is abnormally activated in striatal
regions of HD patients and in animal models of HD.38,39 In this
context, the present data showing that PRE084 can increase
calpastatin expression and thereby control calpain activity can
be of functional significance in HD. It remains to be studied
whether Sig-1R is altered in HD and whether PRE084 or other
Sig-1R ligands may exert beneficial effects in animal models of
HD. Taken together, the results in this study have identified a
signaling pathway mediating neuroprotection in cells
expressing mutant huntingtin involving the Sig-1R and the
calpastatin/NF-kB signaling pathway. The data indicate that
compounds influencing Sig-1R may constitute promising
targets for future drug developments in HD.
Materials and Methods
Cell culture and transfections. PC6.3 neuronal cells were cultured in
RPMI-1600 (Lonza, Basel, Switzerland) medium supplemented with 5% fetal calf
serum (Chemicon, Billerica, MA, USA) and 10% horse serum. Cells were
transfected with expression vectors encoding different CAG-repeat lengths of
huntingtin exon-1 fused to EGFP and FL huntingtin constructs with 17- and
75-polyglutamine repeats, as described earlier.6,9 Transfections were done using
the Transfectin reagent (BioRad, Hercules, CA, USA) with the above plasmids or
with the control EGFP expression plasmid (Clontech, Mountain View, CA, USA).
0,3mM PRE084 (Tocris, Bristol, UK) and 3mM progesterone (Sigma-Aldrich,
St. Louis, MO, USA) were added 4 h after transfection.
Cell viability was determined by the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (Calbiochem) assay as described previously.9,40
Hoechst 33342 (Sigma) was employed to stain dying cells showing condensed
and fragmented DNA.39,40 More than 300 fluorescent cells in each well were
analyzed and experiments were repeated three times. Results are expressed as
percentage of transfected cells.
Immunocytochemistry. PC6.3 cells plated on poly-lysine and laminin-
coated coverslips were fixed for 7 min using 4% paraformaldehyde. Cells were
Figure 6 Sig-1 receptors and its agonist, PRE084 upregulate calpastatin in PC6.3 cells. (a and b) Immunoblot and quantification. Calpastatin level was decreased in cells
expressing 120Q-huntingtin and was restored by using 0.3mMPRE084. b-actin was used as control. Values represent mean±S.D., n¼ 3. **Po0.01 for 120Q versus C. and
for 120Q-PRE084 versus 120Q. (c) Immunoblot. Expression of 120Q-huntingtin induced the appearance of the calpain-specific 145-kDa cleavage product of a-spectrin and
this was reduced by 0.3mM PRE084. Typical blot is shown and was repeated three times. (d and e) Immunoblot and quantification. Stimulation of cells for 24 h with 0.3mM
PRE084 increased calpastatin levels compared with control (lanes 1–3). Overexpression of Sig1-R also increased calpastatin levels (lane 4). Values represent mean±S.D.,
n¼ 3. *Po0.05 for PRE084 versus C and for Sig1-R versus C. (f) Calpastatin mRNA levels were determined in cells expressing either the 17QFL or the 75QFK huntingtin
protein by quantitative PCR using specific primers for calpastatin as described in the Materials and Methods. The mutant 75QFL huntingtin decreased calpastatin mRNA and
this was not significantly counteracted by PRE084. Values are means±S.D., n¼ 3. *Po0.05 for 75QFL versus 17QFL
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incubated for 1 h using phosphate-based saline (PBS) containing 0.1% Triton-X-
100 and 5% bovine serum albumin (Sigma), followed by incubation overnight with
primary Sig-1R (1 : 200; Abcam, Cambridge, UK) and EM48 (1 : 300, Millipore,
Billerica, MA, USA). Cells were washed using PBS and incubated for 1 h using
Alexa594-conjugated secondary antibodies (1 : 300, Molecular Probes, Invitrogen,
Carlsbad, CA, USA). Cells were counterstained for 1 min using Hoechst 33342
blue (4mg/ml; Sigma), mounted in gel mounting medium (DABCO) and analyzed
using a Zeiss LSM confocal microscope (Zeiss, Oberkochen, Germany) at the
Helsinki Biomedicum Molecular Imaging unit. Controls without primary antibodies
showed no staining.
Immunoblots. Cells were lysed in RIPA buffer (150 mM NaCl, 1% Triton-X-
100, 0.5% sodium deoxycholate, 50mM Tris-HCl and 0.1% SDS pH 8.0)
containing phosphatase inhibitor and protease inhibitor cocktail (Roche, Basel,
Schweiz) and protein concentrations were determined by Supersignal West pico
(Thermo Scientific, Rockford, IL, USA). Equal amount of protein (40mg) were
separated on SDS-PAGE and proteins were blotted onto a nitrocellulose filter
(Amersham Biosciences, Piscataway, NJ, USA). Filters were blocked for 1 h in 5%
milk-TBS or 5% BSA-TBS followed by an overnight incubation at 4 1C using
primary antibodies.41,42 These included antibodies against Sig-1R (1 : 1000; Santa
Cruz Biotechnology, Santa Cruz, CA, USA) NF-kB-p65 (1 : 250; Santa Cruz
Biotechnology), SOD1 (1 : 10 000, Santa Cruz Biotechnology), SOD2 (1 : 15 000,
LabFrontier, Seoul, Korea), GFP (1 : 5000; Roche), Trx2 (1 : 1000; LabFrontier),
calpastatin (1 : 1000; Santa Cruz Biotechnology), Bcl-XL (1 : 1500, BD Transduction
Laboratories, San Diego, CA, USA), active caspase-12 (1 : 1000, Chemicon),
active caspase-3 (1 : 350, Cell Signaling Technology), PARP (1 : 1000, Cell
Signaling Technology), calpastatin (1 : 1000 Santa Cruz Biotechnology), a-spectrin
(1 : 1000, Chemicon), and b-actin (1 : 3000; Sigma). After washing, the filters were
incubated with horseradish peroxidase-conjugated secondary antibodies (1 : 2500,
Pierce, Rockford, IL, USA), followed by detection using the enhanced
chemiluminescent method (Pierce).
Solubility assay to detect mutant huntingtin aggregates. Cells
were lysed in buffer containing 50mM Tris-HCl, pH 7.5, 100mM NaCl, 3 mM
EGTA, 0.5% Triton-X and protease inhibitors (Roche) and kept for 5min on ice
and suspended in 3 volumes of SDS loading buffer to obtain the total cell lysate as
described previously.43 Aggregation of huntingtin fragment proteins was observed
by blotting the stacking gel to reveal high-molecular-weight protein species.6
Caspase assay. PC6.3 cells were transfected with 18Q- and 120Q-expressing
plasmids as noted above and 0.3mM PRE084 was added 4 h after transfection as
indicated. Controls were transfected with EGFP expression plasmid. Cells were
incubated for 2 days and caspase-3/7 activities were measured using a Caspase-Glo
assay kit (Promega) as described by the vendor. Samples were incubated at room
temperature for 90min and the luminescence was measured using a luminometer
(GloMax 20/20, Promega, Biofellows, Helsinki, Finland).
Reverse transcription and quantitative PCR. Total RNA was
extracted from cells using the GenElute Mammalian total RNA kit (Sigma) and
gene-specific reverse transcription was performed using Tetro reverse transcrip-
tase (Bioline, London, UK). cDNA synthesis was carried out in a 10-ml reaction
volume containing 1 Tetro reaction buffer, 0.5mM each of the reverse primers
(calpastatin, 50-CCCCAGTAGACTTCTCTTTC-30; Sig1R, 50-CTTCCTCTACATTC
CTCTG-30), 750 ng of the RNA template and 0.5ml Tetro reverse transcriptase.
The reaction was incubated at 75 1C for 5min to open RNA secondary structures,
and samples were cooled to 42 1C. Superscript III reverse transcriptase was then
added and the samples were incubated at 42 1C for 20min followed by
enzyme inactivation for 20min at 64 1C. The unbound reverse transcription
primers were digested with 20 units Exonuclease I (New England Biolabs GmbH,
Frankfurt-Hoechst, Germany) at 37 1C for 30min, followed by denaturation at
80 1C for 15min.
One microliter of product was then amplified with 1 Light Cycler 480 SYBR
Green I Master Mix (Roche Diagnostics GmbH, Mannheim, Germany) and using
0.5mM of forward (fw) and reverse (rev) primers (calpastatin, fw: 50-AGT
AGTTCTGGACCCAATG-30, rev: 50-CCCCAGTAGACTTCTCTTTC-30; Sig1R, fw:
50-TGCCTTATCTCCATTCCA-30, rev: 50-CTCCTTCCTTCAGTCCTT-30). qPCR
amplification and relative quantifications were performed on the Light Cycler 480
II instrument (Roche) using 40 cycles (10 s denaturation at 95 1C, 20 s annealing at
60 1C and 20 s extension at 72 1C) and essentially as described.44 Melting curve
acquisition and analysis was also carried out immediately after amplification to
confirm the specificity of PCR.
Measurement of intracellular ROS. PC6.3 cells were cultured in 96-well
plate and transfected with FL huntingtin constructs with 17- and 75 polyglutamine
repeats for 48 h, 0.3mM PRE084 was added 4 h after transfection. Cells
were treated with 10mM 6-carboxy-20,70-dichlorodihydrofluorescein diacetate,
di(acetoxymethyl ester) (H2DCFDA AM: Invitrogen, Carlsbad, CA, USA) diluted in
PBS buffer and incubated at 37 1C for 45min. H2DCFDA is able to penetrate cells
due to the acetoxymethyl ester, where it is hydrolyzed by intracellular esterases to
form 20,70-dichloro-fluorescin (DCFH). Oxidation of DCFH by hydrogen peroxide and
hydroxyl radicals yields a highly fluorescent product 20,70-dichlorofluorescein (DCF).
The fluorescence intensity of DCF after excitation of the samples at a wavelength of
485 nm was measured at an emission wavelength of 535 nm using a fluorescence
microplate reader. Results are shown as normalized to control (set 100%).
Aequorin-based measurements of Ca2þ concentration in
mitochondria. Measurements of mitochondrial Ca2þ concentration
([Ca2þ ]mito) were carried out using recombinant aequorin targeted to
mitochondrial matrix (mtAeq) and a luminometer system as described
previously.45,46 In brief, cells were grown to 70% confluence on poly-L-lysine-
coated 13-mm glass coverslips and transfected with the mtAeq (kind gift from
Professor U Ruegg, Geneva, Switzerland) along with control (pcDNA), 17QFL- or
75QFL-huntingtin-expressing plasmids as indicated in Figure 3. At 24 h after
transfection, the cells were washed with HBSS buffer (118mM NaCl, 4.6 mM KCL,
1mM CaCl2, 10mM D-glucose, 20mM HEPES, pH 7,4) and reconstituted with
5mM native coelenterazine (Invitrogen, CA, USA) for 1 h at room temperature.
Cells were then placed into a perfusion chamber and the luminescence was
recorded. All measurements were conducted in HBSS at 371C. Cells were
stimulated with 100 nM bradykinin (Sigma-Aldrich, MO, USA) to induce the release
of Ca2þ from the intracellular stores. Calibration of the measurements was done
by permeabilizing the cells in HBSS containing 10mM Ca2þ and 100mM digitonin
(Sigma-Aldrich), thus generating the maximal luminescence of the sample.
Luminescence data was then converted to [Ca2þ ] according to Brini et al.46
Measurement of intracellular calcium. Cells were grown on poly-L-
lysine-coated coverslips and transfected for 24 h as described above. The cells
were then washed three times with HBSS buffer (118mM NaCl, 4.6 mM KCl,
1 mM CaCl2, 10mM D-glucose, 20mM HEPES, pH 7.4), following a 30-min
incubation with 2 mM Fura-2 AM at room temperature. After washing twice using
HBSS, the cells were transferred to a heated coverslip holder adjusted to 37 1C,
and perfused with HBSS containing 100 nM bradykinin. An XBO 75W/2 xenon
lamp served as the source for excitation light and the excitation filters were set at
340 or 380 nm, respectively. Emitted light was measured at 510 nm. Filters were
controlled with Lambda 10-2 (Sutter Instruments, Novato, CA, USA). A SensiCam
CCD camera was employed for image acquisition and the recorded images were
processed using the Axon Imaging Workbench software (Axon Instruments, Foster
City, CA, USA). The F340/F380 fluorescence ratio served as the indication of
intracellular calcium concentrations.
NF-jB reporter assay. PC6.3 cells in six-well plates were transfected with
0.5mg of FL huntingtin expression plasmids in conjunction with 0.5mg of the
NF-kB reporter plasmid, containing multiple NF-kB sites linked to firefly luciferase
gene. A volume of 0.02mg of the Renilla luciferase pRL-TK was used as
control for transfection efficiency. Cells were harvested 48 h after transfection
using Passive Lysis Buffer. Renilla and firefly luciferase activities were measured
using the dual luciferase substrate and a luminometer (GloMax 20/20).25,47
Results are shown as fold increase in luciferase normalized to the Renilla activity.
Quantification and statistics. Immunoblots were quantified with ImageJ
quantification software. Results are expressed as percentage of controls
(mean±S.E.M.). Statistical analyses were performed using one-way ANOVA
and Bonferroni’s multiple comparison tests. Values are given as means±S.E.M.
and Po0.05 was considered as statistically significant.
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